PMID: Front Pharmacol. 2019 ;10:542. Epub 2019 May 21. PMID: 31164821 Abstract Title: Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines. Abstract: Parthenolide (PT) is a sesquiterpene lactone isolated from. In this study, PT showed varying cytotoxic effects against different solid tumor cell lines. HCT116 (p53) …
Continue reading “Parthenolide could be a novel candidate for cancer treatment.”